Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced Melanoma

Clinical Trial ID NCT01614301

PubWeight™ 3.49‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01614301

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Tumor stroma as targets for cancer therapy. Pharmacol Ther 2012 1.06
2 Advances in personalized targeted treatment of metastatic melanoma and non-invasive tumor monitoring. Front Oncol 2013 0.89
3 Chemotherapy and chemoprevention by thiazolidinediones. Biomed Res Int 2015 0.85
4 Biomodulatory metronomic therapy in stage IV melanoma is well-tolerated and may induce prolonged progression-free survival, a phase I trial. J Eur Acad Dermatol Venereol 2015 0.76
Next 100